FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156979835> ?p ?o ?g. }

• W2156979835 endingPage "495" @default.
• W2156979835 startingPage "484" @default.
• W2156979835 abstract "Chemoprevention of prostate cancer by second-generation selenium compounds in reference to selenomethionine holds strong promise to deal with the disease at the root. Here we used the transgenic adenocarcinoma mouse prostate (TRAMP) model to establish the efficacy of methylseleninic acid (MSeA) and methylselenocysteine (MSeC) against prostate carcinogenesis and to characterize potential mechanisms. Eight-week-old male TRAMP mice (C57B/6 background) were given a daily oral dose of water, MSeA, or MSeC at 3 mg Se/kg body weight and were euthanized at either 18 or 26 weeks of age. By 18 weeks of age, the genitourinary tract and dorsolateral prostate weights for the MSeA- and MSeC-treated groups were lower than for the control (P < 0.01). At 26 weeks, 4 of 10 control mice had genitourinary weight >2 g, and only 1 of 10 in each of the Se groups did. The efficacy was accompanied by delayed lesion progression, increased apoptosis, and decreased proliferation without appreciable changes of T-antigen expression in the dorsolateral prostate of Se-treated mice and decreased serum insulin-like growth factor I when compared with control mice. In another experiment, giving MSeA to TRAMP mice from 10 or 16 weeks of age increased their survival to 50 weeks of age, and delayed the death due to synaptophysin-positive neuroendocrine carcinomas and synaptophysin-negative prostate lesions and seminal vesicle hypertrophy. Wild-type mice receiving MSeA from 10 weeks did not exhibit decreased body weight or genitourinary weight or increased serum alanine aminotransferase compared with the control mice. Therefore, these selenium compounds may effectively inhibit this model of prostate cancer carcinogenesis." @default.
• W2156979835 created "2016-06-24" @default.
• W2156979835 creator A5005181620 @default.
• W2156979835 creator A5009983007 @default.
• W2156979835 creator A5010296048 @default.
• W2156979835 creator A5019529182 @default.
• W2156979835 creator A5045260238 @default.
• W2156979835 creator A5065541374 @default.
• W2156979835 creator A5073216396 @default.
• W2156979835 creator A5082769654 @default.
• W2156979835 creator A5044191100 @default.
• W2156979835 date "2009-05-01" @default.
• W2156979835 modified "2023-10-03" @default.
• W2156979835 title "Methyl-Selenium Compounds Inhibit Prostate Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate Model with Survival Benefit" @default.
• W2156979835 cites W1904486154 @default.
• W2156979835 cites W1968751935 @default.
• W2156979835 cites W1980282332 @default.
• W2156979835 cites W2010057554 @default.
• W2156979835 cites W2010930508 @default.
• W2156979835 cites W2014366669 @default.
• W2156979835 cites W2020636054 @default.
• W2156979835 cites W2022205583 @default.
• W2156979835 cites W2022650274 @default.
• W2156979835 cites W2024327408 @default.
• W2156979835 cites W2025192927 @default.
• W2156979835 cites W2025914723 @default.
• W2156979835 cites W2043103956 @default.
• W2156979835 cites W2044826176 @default.
• W2156979835 cites W2048859720 @default.
• W2156979835 cites W2050185172 @default.
• W2156979835 cites W2052732522 @default.
• W2156979835 cites W2053920338 @default.
• W2156979835 cites W2054190001 @default.
• W2156979835 cites W2056098722 @default.
• W2156979835 cites W2059389875 @default.
• W2156979835 cites W2062189587 @default.
• W2156979835 cites W2071291729 @default.
• W2156979835 cites W2084541894 @default.
• W2156979835 cites W2085574028 @default.
• W2156979835 cites W2094999590 @default.
• W2156979835 cites W2095748930 @default.
• W2156979835 cites W2107867112 @default.
• W2156979835 cites W2110105767 @default.
• W2156979835 cites W2112392983 @default.
• W2156979835 cites W2113720631 @default.
• W2156979835 cites W2122291110 @default.
• W2156979835 cites W2129268315 @default.
• W2156979835 cites W2137340845 @default.
• W2156979835 cites W2138405392 @default.
• W2156979835 cites W2141813746 @default.
• W2156979835 cites W2142285790 @default.
• W2156979835 cites W2143157862 @default.
• W2156979835 cites W2146252974 @default.
• W2156979835 cites W2163740497 @default.
• W2156979835 cites W2171943253 @default.
• W2156979835 cites W2276698631 @default.
• W2156979835 cites W3135529189 @default.
• W2156979835 cites W4295115868 @default.
• W2156979835 cites W4362207783 @default.
• W2156979835 doi "https://doi.org/10.1158/1940-6207.capr-08-0173" @default.
• W2156979835 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2822708" @default.
• W2156979835 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19401524" @default.
• W2156979835 hasPublicationYear "2009" @default.
• W2156979835 type Work @default.
• W2156979835 sameAs 2156979835 @default.
• W2156979835 citedByCount "109" @default.
• W2156979835 countsByYear W21569798352012 @default.
• W2156979835 countsByYear W21569798352013 @default.
• W2156979835 countsByYear W21569798352014 @default.
• W2156979835 countsByYear W21569798352015 @default.
• W2156979835 countsByYear W21569798352016 @default.
• W2156979835 countsByYear W21569798352017 @default.
• W2156979835 countsByYear W21569798352018 @default.
• W2156979835 countsByYear W21569798352019 @default.
• W2156979835 countsByYear W21569798352020 @default.
• W2156979835 countsByYear W21569798352021 @default.
• W2156979835 countsByYear W21569798352022 @default.
• W2156979835 countsByYear W21569798352023 @default.
• W2156979835 crossrefType "journal-article" @default.
• W2156979835 hasAuthorship W2156979835A5005181620 @default.
• W2156979835 hasAuthorship W2156979835A5009983007 @default.
• W2156979835 hasAuthorship W2156979835A5010296048 @default.
• W2156979835 hasAuthorship W2156979835A5019529182 @default.
• W2156979835 hasAuthorship W2156979835A5044191100 @default.
• W2156979835 hasAuthorship W2156979835A5045260238 @default.
• W2156979835 hasAuthorship W2156979835A5065541374 @default.
• W2156979835 hasAuthorship W2156979835A5073216396 @default.
• W2156979835 hasAuthorship W2156979835A5082769654 @default.
• W2156979835 hasBestOaLocation W21569798351 @default.
• W2156979835 hasConcept C121608353 @default.
• W2156979835 hasConcept C126322002 @default.
• W2156979835 hasConcept C133507102 @default.
• W2156979835 hasConcept C134018914 @default.
• W2156979835 hasConcept C2776235491 @default.
• W2156979835 hasConcept C2780192828 @default.
• W2156979835 hasConcept C2780940892 @default.
• W2156979835 hasConcept C2781171107 @default.
• W2156979835 hasConcept C2781182431 @default.

• next